Publications by authors named "Binkui Li"

Claim this Profile
T
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA.
Hui-Yan Luo, Wei Wei, Pansong Li, Qi-Hua Zhang, Zhipeng Zhou, Liang Cui, Yong-Bin Lin, Qingfeng Liu, Yuan-Fang Li, Xiao-Jun Lin, Jun-Dong Li, Bin-Kui Li, Yuying Liu, Zhi-Hu Li, Yu-Hua Liu

Cancer Commun (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBV Reactivation in Patients with Hepatocellular Carcinoma Treated with PD-1/L1 Antibodies and Concurrent Antiviral Prophylaxis Agents: A Prospective Observational Study.
Zefeng Du, Zhicheng Lai, Yexing Huang, Hailong Chen, Ping Ma, Qijiong Li, Binkui Li, Li Xu

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of SOX9 and Its Combination With RAS and TP53 Mutations Following Colorectal Cancer Liver Metastasectomy.
Jian-Li Duan, Lei Wen, Yan-Yu Cai, Ke-Min Jin, Xiao-Yun Liu, Li-Ren Li, Bin-Kui Li, Yu-Hong Li

FASEB J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus regarding the clinical application of liver contrast-enhanced US with Sonazoid (Sonazoid CEUS).
Jianhua Zhou, Lingling Li, Kun Yan, Yuanyi Zheng, Tian'An Jiang, Yu Li, Binkui Li, Jie Li, Kai-Yan Li, Qian Li, Fangyi Liu, Guang-Jian Liu, Liping Liu, Li Qiu, Lijun Wang, Xiaoling Yu, Ping Liang

Int J Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma.
Yichuan Yuan, Yi Niu, Zhenkun Huang, Yunxing Shi, Zhu Lin, Kai Li, Binkui Li

Proc Natl Acad Sci U S A· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1.
Zhiwen Yang, Yichuan Yuan, Yi Niu, Dinglan Zuo, Wenwu Liu, Kai Li, Keren Li, Zhu Lin, Jiliang Qiu, Binkui Li

Cell Oncol (Dordr)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous hepatic artery infusion chemotherapy with oxaliplatin and fluoropyrimidines in treatment-resistant colorectal cancer patients with unresectable liver metastases: a retrospective cohort study.
William Pat Fong, Zi-Jing Li, Chao Ren, Wen-Long Guan, Meng-Xuan Zuo, Bin-Kui Li, Yu-Hong Li

HPB (Oxford)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrast-enhanced intraoperative ultrasound improved hepatic recurrence-free survival in initially unresectable colorectal cancer liver metastases.
HuiFang Li, Ming Shi, Xingzhang Long, Pinzhu Huang, Chuan Peng, Yuhong Li, Binkui Li, JiLiang Qiu

Dig Liver Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Treatment for Unresectable Hepatocellular Carcinoma: A Surgeon's Perspective.
Xiao-Dong Zhu, Lei Zhao, Binkui Li, Yuan Cheng, Hui-Chuan Sun

J Hepatocell Carcinoma· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis predictors of hepatocellular carcinoma after hepatectomy following conversion therapy.
Shaoru Liu, Zongfeng Wu, Chenwei Wang, Liang Qiao, Zhenkun Huang, Binkui Li, Jiliang Qiu

Eur J Surg Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of adjuvant FOLFOX/FOLFIRI with versus without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastasectomy (HARVEST trial): A randomized controlled trial.
De-Shen Wang, William Pat Fong, Lei Wen, Yan-Yu Cai, Chao Ren, Bin-Kui Li, Li-Ren Li, Yu-Hong Li

Eur J Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus-related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial.
Yichuan Yuan, Hong Peng, Wei He, Yun Zheng, Jiliang Qiu, Binkui Li

Cancer Commun (Lond)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separation.
Dan-Ling Dai, Chu Xie, Lan-Yi Zhong, Shang-Xin Liu, Le-Le Zhang, Yan Li, Tian-Liang Xia, Mei-Ling Chen, Yuan-Tao Liu, Shu-Xin Li, Lingqiang Zhang, Bin-Kui Li

Signal Transduct Target Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation model of hepatic steatosis based on CT value and serum uric acid/HDL cholesterol ratio can predict intrahepatic recurrence of colorectal cancer liver metastasis.
Yuan Li, E-Er-Man-Bie-Ke Jin-Si-Han, Cheng Feng, Weili Zhang, Hao Wang, Shaopu Lian, Binkui Li

Int J Clin Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab and bevacizumab plus transarterial chemoembolization and hepatic arterial infusion chemotherapy for patients with high tumor burden unresectable hepatocellular carcinoma: A multi-center cohort study.
Zhenkun Huang, Tiejun Chen, Wenbin Li, Wei He, Shaoru Liu, Binkui Li, Jiliang Qiu

Int Immunopharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling.
Yunxing Shi, Zongfeng Wu, Shaoru Liu, Dinglan Zuo, Yi Niu, Liang Qiao, Jiliang Qiu, Binkui Li

Nat Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mA-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma.
Zhu Lin, Zhenkun Huang, Jiliang Qiu, Yunxing Shi, Dinglan Zuo, Binkui Li

J Exp Clin Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoacylglycerol acyltransferase-2 inhibits colorectal carcinogenesis in APC mice.
Yanhong Lang, Chengrui Zhong, Lingling Guo, Zhijie Liu, Dinglan Zuo, Liuyan Ding, Binkui Li, Jiliang Qiu

iScience· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 inhibitor versus PD-1 inhibitor plus bevacizumab with transvascular intervention in unresectable hepatocellular carcinoma.
Zhenkun Huang, Tiejun Chen, Wenbin Li, Jiliang Qiu, Shaoru Liu, Binkui Li

Clin Exp Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KLF4 Suppresses the Progression of Hepatocellular Carcinoma by Reducing Tumor ATP Synthesis through Targeting the Mir-206/RICTOR Axis.
Yongjin Wang, Dinglan Zuo, Zhenkun Huang, Yuxiong Qiu, Zongfeng Wu, Shaoru Liu, Binkui Li, Jiliang Qiu

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study.
Binkui Li, Chenwei Wang, Wei He, Jiliang Qiu, Yun Zheng, Zhu Lin

Int J Surg· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study.
Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Shaoru Liu, Jiliang Qiu, Binkui Li

Cancer Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
De-Shen Wang, Chao Ren, Shan-Shan Li, William Pat Fong, Xiao-Jun Wu, Bin-Kui Li, Ling-Yun Wang, Li-Ren Li, Tian-Shu Liu, Yu-Hong Li

PLoS Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma.
Yunxing Shi, Kai Li, Yichuan Yuan, Chenwei Wang, Zhiwen Yang, Jiliang Qiu, Binkui Li

Cancer Cell Int· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RFX6 facilitates aerobic glycolysis-mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1.
Zhiyu Qiu, Chenwei Wang, Pinzhu Huang, Yichuan Yuan, Yunxing Shi, Zhu Lin, Jiliang Qiu, Binkui Li

Clin Transl Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis